DGAT2 divergent transcript (DGAT2-DT)

DGAT2 divergent transcript (DGAT2-DT, CTD-2530H12.1) refers to a transcript associated with the DGAT2 gene region, but it is not the same as the protein-coding Diacylglycerol O-acyltransferase 2 enzyme[1]. While DGAT2 encodes an enzyme crucial for triglyceride biosynthesis[1], there is no evidence that DGAT2-DT encodes a functional protein, acts as a receptor, or serves as a direct therapeutic target. Most available database entries referencing DGAT2-DT (or its aliases) classify it as a divergent, likely non-coding, RNA with currently no known molecular function or disease association. It is therefore not an established drug target and does not fit typical molecular families such as enzyme, transporter, or receptor. Key points: - The query describes a divergent transcript (DGAT2-DT), not the canonical protein (DGAT2) or any established therapeutic target. - There is no evidence of it being a protein coding gene, nor of any associated drugs, biological functions, or disease roles. - It is likely mischaracterized if used as a therapeutic target or canonical drug target class. - For information about a true therapeutic target, see "Diacylglycerol O-acyltransferase 2" (DGAT2)[1], which is an enzyme and a possible metabolic disease drug target. If you require structured information for the canonical DGAT2 enzyme instead, please clarify.

Other names

CTD-2530H12.1DGAT2-DT